Go Pro
NASDAQ:SRTA

Strata Critical Medical (SRTA) Stock Price, News & Analysis

$5.31 -0.01 (-0.19%)
Closing price 09/8/2026 04:00 PM Eastern
Extended Trading
$5.29 -0.02 (-0.30%)
As of 09/8/2026 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Strata Critical Medical Stock (NASDAQ:SRTA)

Advanced

Key Stats

Today's Range
$5.22
$5.35
50-Day Range
$4.87
$6.24
52-Week Range
$3.85
$6.50
Volume
879,482 shs
Average Volume
795,594 shs
Market Capitalization
$469.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
Consensus Rating
Moderate Buy

Company Overview

Blade Air Mobility, Inc. provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.

Strata Critical Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
40th Percentile Overall Score

SRTA MarketRank™: 

Strata Critical Medical scored higher than 40% of companies evaluated by MarketBeat, and ranked 652nd out of 908 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Strata Critical Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 1 strong buy rating, 1 buy rating, 2 hold ratings, and no sell ratings.

  • Upside Potential

    Strata Critical Medical has a consensus price target of $8.00, representing about 50.7% upside from its current price of $5.31.

  • Amount of Analyst Coverage

    Strata Critical Medical has only been the subject of 1 research reports in the past 90 days.

  • Read more about Strata Critical Medical's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Strata Critical Medical is -132.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Strata Critical Medical is -132.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Strata Critical Medical has a P/B Ratio of 1.65. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    5.61% of the float of Strata Critical Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Strata Critical Medical has a short interest ratio ("days to cover") of 3.25, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Strata Critical Medical has recently decreased by 0.16%, indicating that investor sentiment is improving.
  • Dividend Yield

    Strata Critical Medical does not currently pay a dividend.

  • Dividend Growth

    Strata Critical Medical does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 1 news article for Strata Critical Medical this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    2 people have added Strata Critical Medical to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Strata Critical Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $29,273.00 in company stock.

  • Percentage Held by Insiders

    15.50% of the stock of Strata Critical Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    47.36% of the stock of Strata Critical Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Strata Critical Medical's insider trading history.
Receive SRTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Strata Critical Medical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SRTA Stock News Headlines

ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
See More Headlines

SRTA Stock Analysis - Frequently Asked Questions

Strata Critical Medical's stock was trading at $4.38 on March 25, 2026. Since then, SRTA stock has increased by 21.2% and is now trading at $5.31.

Top institutional shareholders of Strata Critical Medical include AWM Investment Company Inc. (3.26%), Squarepoint Ops LLC (0.13%), Corient Private Wealth LP (0.03%) and Allied Private Wealth LLC (0.01%). Insiders that own company stock include Melissa M Tomkiel, William A Heyburn, Amir Cohen and Reginald Love.
View institutional ownership trends
.

Shares of SRTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
9/08/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NASDAQ:SRTA
CIK
1779128
Fax
N/A
Employees
130
Year Founded
N/A

Price Target and Rating

High Price Target
$8.00
Low Price Target
$8.00
Potential Upside/Downside
+50.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$41.35 million
Net Margins
15.71%
Pretax Margin
-9.05%
Return on Equity
-2.97%
Return on Assets
-2.54%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.64
Quick Ratio
2.64

Sales & Book Value

Annual Sales
$197.14 million
Price / Sales
2.38
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.22 per share
Price / Book
1.65

Miscellaneous

Outstanding Shares
88,470,000
Free Float
74,755,000
Market Cap
$469.78 million
Optionable
N/A
Beta
2.26
10 Best Stocks to Own - Fall 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:SRTA) was last updated on 9/9/2026 by MarketBeat.com Staff.
From Our Partners